Northern Trust Corp Cellectar Biosciences, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
BUY
$15.2 - $25.0 $775,412 - $1.28 Million
51,014 Added 114.83%
95,438 $154,000
Q4 2020

Feb 11, 2021
BUY
$11.2 - $27.7 $216,596 - $535,690
19,339 Added 77.09%
44,424 $92,000
Q3 2020

Nov 16, 2020
BUY
$10.6 - $16.6 $265,901 - $416,411
25,085 New
25,085 $31,000

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $13M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email